Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer
D. Hany, M. Zoetemelk, K. Bhattacharya, P. Nowak-Sliwinska, D. Picard
The paper identifies effective low-dose multidrug combinations for ER+/HER2-/PI3Kα-mutant breast cancer using network analysis and experimental validation.
bioRxiv · Aug 30, 2022Cancer Biology